Kaplan lecture 2023: lymphopenia in particle therapy.
Marco DurantePublished in: International journal of radiation biology (2024)
There is nowadays an overwhelming evidence that particle therapy reduces significantly the radiotherapy-induced lymphopenia in several tumor sites. Because lymphopenia turns down the immune response to checkpoint inhibitors, it can be predicted that particle therapy may be the ideal partner for combined radiation and immunotherapy treatment and should be selected for patients where severe lymphopenia is expected after X-rays.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- radiation therapy
- radiation induced
- stem cells
- squamous cell carcinoma
- early onset
- cell cycle
- mesenchymal stem cells
- peritoneal dialysis
- hepatitis c virus
- high glucose
- cell therapy
- endothelial cells
- patient reported outcomes
- chemotherapy induced